About Palamedrix
Palamedrix is a Healthcare company based in San Diego (United States) founded in 2017, and was acquired by Somalogic in July 2022. Developer of a multi-omics platform for therapeutics and diagnostics. Its focus areas include Life Sciences, Genomics, Genome Informatics and Integrative Bioinformatics Platforms. Its competitors include Helix, Benchling and BioAge Labs; 3 of its 3 listed competitors have raised funding.
Company details
Palamedrix was founded in 2017 in San Diego, United States, within the biotechnology sector. A multi-omics platform is developed by the company, incorporating DNA nanotechnology and biosensors to create a modular solution for molecule counting in fluids. Biological samples are analyzed for molecule detection through services including molecular biosensors on chips, sensor integration with CMOS chips, microfluidic sample delivery, chip-reading instrumentation, and data analytics.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Website palamedrix.com
- Social LinkedIn
- Acquired by Somalogic (Jul 2022)
Investors in Palamedrix
Palamedrix has secured backing from 1 investor. Prominent investors backing the company include Somalogic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Protein-based assays are developed for life science research. | 1999 | somalogic.com | Boulder, United States |
Investor details for Palamedrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Palamedrix
2 dated milestones of Palamedrix across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Palamedrix is founded.
- Exit Acquired by Somalogic.
Competitors of Palamedrix
Palamedrix has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and BioAge Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. |
Detailed competitors of Palamedrix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Palamedrix (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Palamedrix
Complete news archive for Palamedrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Palamedrix
Palamedrix was founded in 2017.
Palamedrix is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Palamedrix was founded in 2017 in San Diego, United States, within the biotechnology sector. A multi-omics platform is developed by the company, incorporating DNA nanotechnology and biosensors to create a modular solution for molecule counting in fluids. Biological samples are analyzed for molecule detection through services including molecular biosensors on chips, sensor integration with CMOS chips, microfluidic sample delivery, chip-reading instrumentation, and data analytics.
Palamedrix's top competitors include Helix, Benchling and BioAge Labs.
Palamedrix has 1 investor. Key investors include Somalogic.
Yes. Palamedrix was acquired by Somalogic in July 2022.